Cargando…

Structural basis for plazomicin antibiotic action and resistance

The approval of plazomicin broadened the clinical library of aminoglycosides available for use against emerging bacterial pathogens. Contrarily to other aminoglycosides, resistance to plazomicin is limited; still, instances of resistance have been reported in clinical settings. Here, we present stru...

Descripción completa

Detalles Bibliográficos
Autores principales:	Golkar, Tolou, Bassenden, Angelia V., Maiti, Krishnagopal, Arya, Dev P., Schmeing, T. Martin, Berghuis, Albert M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8195987/ https://www.ncbi.nlm.nih.gov/pubmed/34117352 http://dx.doi.org/10.1038/s42003-021-02261-4

Ejemplares similares

Structural and phylogenetic analyses of resistance to next-generation aminoglycosides conferred by AAC(2′) enzymes
por: Bassenden, Angelia V., et al.
Publicado: (2021)

Look and Outlook on Enzyme-Mediated Macrolide Resistance
por: Golkar, Tolou, et al.
Publicado: (2018)

Plazomicin: a new aminoglycoside in the fight against antimicrobial resistance
por: Clark, Justin A., et al.
Publicado: (2020)

Plazomicin against Multidrug-Resistant Bacteria: A Scoping Review
por: Alfieri, Aniello, et al.
Publicado: (2022)

Inhibition of Enzymatic Acetylation-Mediated Resistance to Plazomicin by Silver Ions
por: Ngo, David, et al.
Publicado: (2023)

Evaluation of the Bactericidal Activity of Plazomicin and Comparators against Multidrug-Resistant Enterobacteriaceae
por: Thwaites, M., et al.
Publicado: (2018)

Plazomicin Is Active Against Metallo-β-Lactamase-Producing Enterobacteriaceae
por: Serio, Alisa W, et al.
Publicado: (2019)

1227. Plazomicin Susceptibility Testing using ETEST(®) MIC for Enterobacterales
por: Ying, Yun, et al.
Publicado: (2020)

Nationwide epidemiology of carbapenem resistant Klebsiella pneumoniae isolates from Greek hospitals, with regards to plazomicin and aminoglycoside resistance
por: Galani, Irene, et al.
Publicado: (2019)

Multicenter Clinical Evaluation of ETEST Plazomicin (PLZ) for Susceptibility Testing of Enterobacterales
por: Blanchard, Laurine S., et al.
Publicado: (2022)

1400. Mass Balance, Metabolism, and Excretion of [(14)C]-Plazomicin in Healthy Human Subjects
por: Choi, Taylor, et al.
Publicado: (2018)

Correction to: Nationwide epidemiology of carbapenem resistant Klebsiella pneumoniae isolates from Greek hospitals, with regards to plazomicin and aminoglycoside resistance
por: Galani, Irene, et al.
Publicado: (2019)

2801. Antimicrobial Spectrum of Plazomicin and Other Aminoglycosides against Multidrug-Resistant and Carbapenem-Resistant Enterobacterales When Applying New Breakpoints
por: Sader, Helio S, et al.
Publicado: (2023)

249 Activity of Plazomicin Against Contemporary Isolates of Enterobacteriaceae from New York City
por: Olafisoye, Olawole, et al.
Publicado: (2014)

Teaching an Old Class New Tricks: A Novel Semi-Synthetic Aminoglycoside, Plazomicin
por: Abdul-Mutakabbir, Jacinda C., et al.
Publicado: (2019)

Prospects for circumventing aminoglycoside kinase mediated antibiotic resistance
por: Shi, Kun, et al.
Publicado: (2013)

2060. Comparison of Plazomicin MIC Test Strip and Broth Microdilution MIC Results for 125 Enterobacteriaceae
por: Koeth, Laura, et al.
Publicado: (2018)

Efficacy and Safety of Plazomicin in the Treatment of Enterobacterales Infections: A Meta-analysis of Randomized Controlled Trials
por: Yan, Kaicheng, et al.
Publicado: (2022)

2162. Comparison of Plazomicin Disk Diffusion vs. Gradient Diffusion Susceptibility Testing Results Against Drug-Resistant Clinical Enterobacteriaceae Isolates
por: Lepak, Alexander, et al.
Publicado: (2019)

1348. In vitro Activity of Plazomicin, a Next-Generation Aminoglycoside, Against Carbapenemase-Producing Klebsiella pneumoniae
por: Jacobs, Michael R, et al.
Publicado: (2018)

1229. Antimicrobial Activity of Plazomicin against Multidrug-resistant Enterobacterales: Results from 3 Years of Surveillance in Hospitals in the United States (2018–2020)
por: Carvalhaes, Cecilia G, et al.
Publicado: (2021)

A Phase 1 Study To Assess the Pharmacokinetics of Intravenous Plazomicin in Adult Subjects with Varying Degrees of Renal Function
por: Komirenko, Allison S., et al.
Publicado: (2018)

Population Pharmacokinetic Analyses for Plazomicin Using Pooled Data from Phase 1, 2, and 3 Clinical Studies
por: Trang, Michael, et al.
Publicado: (2019)

Structural Basis for Carbapenem-Hydrolyzing Mechanisms of Carbapenemases Conferring Antibiotic Resistance
por: Jeon, Jeong Ho, et al.
Publicado: (2015)

Structural Basis for the Antibiotic Resistance of Eukaryotic Isoleucyl-tRNA Synthetase
por: Chung, Scisung, et al.
Publicado: (2020)

Structural basis for PoxtA-mediated resistance to phenicol and oxazolidinone antibiotics
por: Crowe-McAuliffe, Caillan, et al.
Publicado: (2022)

Structural basis for HflXr-mediated antibiotic resistance in Listeria monocytogenes
por: Koller, Timm O, et al.
Publicado: (2022)

Structural and functional insights into esterase-mediated macrolide resistance
por: Zieliński, Michał, et al.
Publicado: (2021)

Glycosidic Bond Expanded Cyclic Oligosaccharides: Synthesis and Host–Guest Binding Property of a Cyclic Pentasaccharide
por: Samanta, Gopal Ch, et al.
Publicado: (2018)

1964. Microbiological Outcomes With Plazomicin (PLZ) vs. Colistin (CST) in Patients With Bloodstream Infections (BSI) Caused by Carbapenem-Resistant Enterobacteriaceae (CRE) in the CARE Study
por: Serio, Alisa W, et al.
Publicado: (2018)

Structural and Molecular Basis for Resistance to Aminoglycoside Antibiotics by the Adenylyltransferase ANT(2″)-Ia
por: Cox, Georgina, et al.
Publicado: (2015)

A Physiological Basis for Nonheritable Antibiotic Resistance
por: Pontes, Mauricio H., et al.
Publicado: (2020)

Structural basis for antibiotic resistance mediated by the Bacillus subtilis ABCF ATPase VmlR
por: Crowe-McAuliffe, Caillan, et al.
Publicado: (2018)

Impact of the Recent Clinical and Laboratory Standards Institute Breakpoint Changes on the Antimicrobial Spectrum of Aminoglycosides and the Activity of Plazomicin Against Multidrug-Resistant and Carbapenem-Resistant Enterobacterales From United States Medical Centers
por: Sader, Helio S, et al.
Publicado: (2023)

Editorial: Genomic Basis of Antibiotic Resistance and Virulence in Acinetobacter
por: Evans, Benjamin A., et al.
Publicado: (2021)

Chemical Basis of Combination Therapy to Combat Antibiotic Resistance
por: Si, Zhangyong, et al.
Publicado: (2023)

Activity of Plazomicin (ACHN-490) against MDR clinical isolates of Klebsiella pneumoniae, Escherichia coli, and Enterobacter spp. from Athens, Greece
por: Galani, Irene, et al.
Publicado: (2012)

Structural and mechanistic basis for translation inhibition by macrolide and ketolide antibiotics
por: Beckert, Bertrand, et al.
Publicado: (2021)

De novo TRPV4 Leu619Pro variant causes a new channelopathy characterised by giant cell lesions of the jaws and skull, skeletal abnormalities and polyneuropathy
por: Ragamin, Aviel, et al.
Publicado: (2022)

Structural basis for promiscuous action of monoterpenes on TRP channels
por: Nguyen, Thi Hong Dung, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_li0omo4tq3sqhvpsjq52nld03b